Research programme: glucokinase stimulants - Banyu
Alternative Names: Cpd B; Cpd CLatest Information Update: 16 Jul 2016
At a glance
- Originator Banyu
- Class Small molecules
- Mechanism of Action Glucokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in Japan
- 09 Oct 2009 Pharmacodynamics data from animal studies in type-2 diabetes mellitus presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD-2009)
- 09 Jun 2009 Preclinical trials in Type-2 diabetes mellitus in Japan (unspecified route)